Cel-Sci Corporation (CVM)
Cel-Sci Corporation (CVM) is a biotechnology company focused on developing immunotherapy treatments for cancer and other diseases. Known for its flagship product, Multikine, a cytokine-based immunotherapy aimed at boosting the immune response against tumors, Cel-Sci aims to improve therapeutic options for patients with various cancers. The company also engages in research and development of other immunomodulatory therapies.
Company News
The article discusses three emerging growth stock ideas from the 2024 Think Equity Conference, including Cel-Sci, NetSol Technologies, and United States Antimony Corporation.
Shares of U Power Limited (NASDAQ: UCAR) shares moved lower during Monday’s session after the company announced pricing of registered follow-on offering of 10 million units at a purchase price of $1.20 per unit. U Power shares dipped 54% to $0.7090 on Monday. Here are some other stocks moving in today's mid-day session. Gainers EyePoint Pharm...
Should you invest in penny stocks right now? The post The Best Stocks To Invest In Right Now? 3 Penny Stocks To Watch appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
The company attempted to clarify "confusion" related to its recent late-stage clinical results.